Interpreting The Cooper Companies (COO) International Revenue Trends

The Cooper Companies (COO) reported quarterly revenue of $1.06 billion, a 5.7% year-over-year increase, with international operations showing varied performance. EMEA revenue reached $292.1 million (27.6% of total), exceeding Wall Street projections by 9.11%, while Asia Pacific revenue was $140.3 million (13.2% of total), falling short of expectations by 2.35%. Analysts project full-year revenue of $4.1 billion, up 5.3%, underscoring the critical role of international markets for COO's growth and diversification, even as the stock has recently underperformed the broader market.

Analysis

The Cooper Companies (COO) demonstrated solid top-line growth in its July 2025 quarter, with total revenue increasing 5.7% year-over-year to $1.06 billion. However, a deeper look at its international operations reveals a mixed performance. The EMEA region was a significant source of strength, delivering $292.1 million in revenue and beating Wall Street estimates by a substantial 9.11%. This performance also increased EMEA's share of total revenue to 27.6% from 25.6% in the year-ago quarter. In contrast, the Asia Pacific region underperformed, with its $140.3 million in revenue missing analyst expectations by 2.35%. Despite the solid overall growth and the EMEA beat, the market appears focused on the regional weakness and future outlook, as reflected in the stock's recent underperformance. Over the past three months, COO's stock has declined 6.8%, starkly contrasting with a 9.7% gain in the S&P 500 and a 3.4% rise in its broader medical sector. This divergence suggests investor caution, which is further supported by a neutral Zacks Rank #3 (Hold) rating and full-year revenue growth projections of 5.3%, implying a slight deceleration from the most recent quarter.

Key Decisions for Investors

• Investors should weigh the conflicting signals of strong overall revenue growth driven by a 9.11% beat in EMEA against the concerning 2.35% revenue miss in the Asia Pacific region.
• The stock's significant underperformance over the past three months, where it declined 6.8% against a rising market and sector, indicates that the market may be pricing in risks such as the APAC slowdown or geopolitical headwinds over the headline growth figures.
• Given the mixed regional results and neutral 'Hold' rating, a prudent approach would be to monitor for a recovery in the Asia Pacific segment and confirmation that the company is on track to meet its 4% revenue growth projection for the current quarter before committing new capital.